Liu et al demonstrated that silencing ADORA1 expression in human melanoma cell lines significantly increased tumor PD-L1 levels and inhibited T cell-mediated cytotoxicity by conducting T cell-mediated cancer cell-killing assays 11. Here, CD274 is linked to neoplasm.